Key Takeaways:
- Aceso Life Sci to raise its stake in IFGL to 30.70 percent.
- The HKD 167 million deal is funded by issuing 1.349 billion new shares.
- Imagi Int'l's ownership of IFGL will be diluted to 68.39 percent.
Back
Aceso Life Sci boosts IFGL stake to 30.7% in HKD 167M deal
Aceso Life Science will increase its stake in financial services firm IFGL to 30.7 percent through a HKD 167 million share subscription.
The transaction was detailed in a company announcement on the Hong Kong Stock Exchange.
Aceso will subscribe to 2,102 new shares in IFGL. The HKD 167 million consideration will be satisfied by the issuance of 1.349 billion new Aceso shares at HKD 0.12 each. This price is equivalent to the stock's closing price on the day of the announcement.
Upon completion, Aceso's ownership in IFGL will rise from 19.74 percent, while Imagi International Holdings' (00585.HK) stake will be diluted from 79.21 percent to 68.39 percent. The deal also increases IFGL's holding in Aceso to 28 percent from 16.67 percent.
This strategic move tightens Aceso's control over IFGL, an integrated financial services provider, and realigns the ownership structure between the three entities. The share-based payment method avoids a cash outlay for Aceso while creating a larger cross-holding between it and its affiliate IFGL.
The market reacted positively to the news, with Aceso Life Sci's shares climbing over five percent. Investors will watch for the completion of the deal to assess the long-term value creation from the consolidated financial services investment.
This article is for informational purposes only and does not constitute investment advice.
